Concurrent inhibition of the RAS ERK-MAPK pathway and PIKfyve as a therapeutic strategy for pancreatic cancer

被引：0
|
作者：
DeLiberty, Jonathan M.
Roach, Mallory K.
Stalnecker, Clint A.
Robb, Ryan
Schechter, Elyse G.
Pieper, Noah L.
Yang, Runying
Bang, Scott
Taylor, Khalilah E.
Drizyte-Miller, Kristina
Morris, John P.
Der, Channing J.
Cox, Adrienne D.
Bryant, Kirsten L.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 17期
关键词：
D O I：
10.1158/1538-7445.PANCREATIC24-C026
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C026
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Improving the efficacy of dual ERK-MAPK and autophagy inhibition as a therapeutic strategy for pancreatic ductal adenocarcinoma
    DeLiberty, Jonathan M.
    Roach, Mallory K.
    Pieper, Noah L.
    Drizyte-Miller, Kristina
    Schechter, Elyse G.
    Yang, Runying
    Der, Channing J.
    Cox, Adrienne D.
    Stalnecker, Clint A.
    Bryant, Kirsten L.
    CANCER RESEARCH, 2024, 84 (02)
  • [2] Improving the efficacy of dual ERK-MAPK and autophagy inhibition as a therapeutic strategy for pancreatic ductal adenocarcinoma
    DeLiberty, Jonathan M.
    Stalnecker, Clint A.
    Drizyte-Miller, Kristina
    Schechter, Elyse G.
    Pieper, Noah L.
    Yang, Runying
    Der, Channing J.
    Cox, Adrienne D.
    Bryant, Kirsten L.
    CANCER RESEARCH, 2023, 83 (07)
  • [3] Dual inhibition of PIKfyve and KRAS/MAPK as a potential for therapeutic strategy for pancreatic ductal adenocarcinoma
    Wisniewski, Jasmine P.
    Cheng, Caleb
    Jackson, Bailey
    Korkaya, Ahmet
    Peters, Sydney
    Qiao, Yuanyuan
    Lyssiotis, Costas A.
    Chinnaiyan, Arul M.
    CANCER RESEARCH, 2024, 84 (06)
  • [4] FAM172A inhibits EMT in pancreatic cancer via ERK-MAPK signaling
    Chen, Ying
    Liu, Peihui
    Shen, Di
    Liu, Han
    Xu, Lepeng
    Wang, Jian
    Shen, Daguang
    Sun, He
    Wu, Hongkui
    BIOLOGY OPEN, 2020, 9 (02):
  • [5] Inhibition of the Ras/Raf/MAPK-pathway in GIST: Therapeutic potential?
    Philipps, E. S.
    Muehlenberg, T.
    Simon, S.
    Ecken, S.
    Grabellus, F.
    Taeger, G.
    Schuler, M.
    Bauer, S.
    ONKOLOGIE, 2011, 34 : 235 - 235
  • [6] Vertical inhibition of the autophagy pathway enhances sensitization to RAS MAPK pathway inhibition in pancreatic ductal adenocarcinoma
    Roach, Mallory K.
    DeLiberty, Jonathan M.
    Schechter, Elyse G.
    Yang, Runying
    Pieper, Noah L.
    Stalnecker, Clint A.
    Bryant, Kirsten L.
    CANCER RESEARCH, 2024, 84 (17)
  • [7] PIKfyve as a potential therapeutic target in pancreatic cancer
    Grenier, Shea
    Galapate, Cheska
    Zhang, Yijuan
    Arora, Gurpreet
    Olson, Steven
    Emerling, Brooke
    Commisso, Cosimo
    CANCER RESEARCH, 2024, 84 (02)
  • [8] Ox-LDL induced lipid degeneration of hepatocyte by ERK-MAPK pathway
    Guo, Wen
    Li, Xinyan
    Yuan, Kui
    Qiu, Enqi
    Hu, Xianfu
    Chen, Min
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 627 - 628
  • [9] Constitutive activation of the ERK-MAPK pathway in the suprachiasmatic nuclei inhibits circadian resetting
    Hainich, Ernesto C.
    Pizzio, Gaston A.
    Golombek, Diego A.
    FEBS LETTERS, 2006, 580 (28-29): : 6665 - 6668
  • [10] Ras-MAPK Pathway as a Therapeutic Target in Cancer - Emphasis on Bladder Cancer
    Dangle, Pankaj P.
    Zaharieva, Boriana
    Jia, Hongtao
    Pohar, Kamal S.
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2009, 4 (02) : 125 - 136
12345